Weekly Roundup: June 15-19


ICYMI, this week’s edition features articles about laser therapy for BCC, the growing interest in JAK-STAT inhibition, tips on how to sell your practice, apremilast for scalp pruritus, plus more.

In case you missed it, among our many stories featured this week, we looked at oral apremilast for scalp pruritis, maintenance therapy for basal cell carcinoma (BCC), a new pediatric dermatology conference launching at the end of June, ixekizumab for possible treatment of genital psoriasis, the increasing interest in JAK-STAT inhibition relative to various skin diseases, and the expanding treatment options for acne and rosacea.

Ixekizumab offers quick, lasting relief for genital psoriasis

A recent study shows ixekizumab may be effective for the treatment of moderate-to-severe cases of genital psoriasis.

Laser therapy may be practical for some basal cell carcinomas

For nonaggressive basal cell carcinomas, laser therapy could be a practical treatment and management solution, according to the authors of a recent review.

JAK-STAT inhibition an attractive target for atopic dermatitis drugs

Jonathan H. Zippin, M.D., Ph.D., provides insight into the role of investigational JAK-STAT inhibitors in the treatment of atopic dermatitis, alopecia areata, vitiligo and psoriasis.

Portable sink makes handwashing easier during COVID-19

Project Process, a startup from Purdue University, seeks to make handwashing easier and more accessible during COVID-19 through its new portable bedside sink technology.

Oral apremilast effectively treats scalp psoriasis

A recent article shows oral apremilast may rapidly and significantly improve moderate-to-severe scalp psoriasis.

Selling your practice: Prepare for negotiation

The next two steps in the Selling Your Practice process are perhaps the most important: preparing to clearly understand what you desire from a sale of your practice and understanding its true value on the open market.

Maintenance therapy for basal cell carcinoma proves effective

Researchers investigated the long-term efficacy of low-dose vismodegib in patients with locally advanced basal cell carcinoma who achieved complete remission.

More treatment options emerging for acne, rosacea

Thanks to new molecules, new formulations and combinations of old molecules, the number of emerging therapies for acne and rosacea is exploding, says Zoe Diana Draelos, M.D.

New pediatric dermatology conference open for registration

The Inaugural Pediatric Dermatology 2020: Best Practices and Innovations Conference is now open for registration and scheduled to take place June 27th, offering seven free CME credits.

How to perfect the cosmetic injectable consultation

Vince Bertucci, M.D., offers tips for building trust and addressing concerns during a cosmetic patient consultation.

How to manage your dermatology practice’s online reputation

Ashley Buehnerkemper, director of marketing at VitalSkin Dermatology, shares the essentials of managing your dermatology practice’s online reputation.

Evidence Skincare offers complementary skin surveys

Evidence Skincare is now offering consumers a complementary skin survey to help identify consumers' problem areas, recommend skincare regimens and provide suggestions on what products might work best for them.

Related Videos
© 2023 MJH Life Sciences

All rights reserved.